Trial Profile
A two part study to compare the pharmacological effects of recombinant human chorionic gonadotrophin (rhCG/Ovidrel) versus urinary human chorionic gonadotrophin (uhCG/Pregnyl) given as subcutaneous injection to healthy men following supression of endogenous testosterone (T) and luteinising hormone (LH) with nandrolone decanoate(ND).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Chorionic gonadotropin
- Indications Male infertility
- Focus Pharmacodynamics; Pharmacokinetics
- 08 Jun 2016 Status changed from not yet recruiting to completed.
- 23 Jun 2009 New trial record